ZIM
BRLI

Zacks Investment Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Zacks Investment Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,174
Closed -$229K – 829
2014
Q3 		$229K Buy
+8,174
New +$249K 0.01% 611

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zacks Investment Management's BRLI Position: Q4 2014 in Review

Zacks Investment Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q4 2014, closing a stake of 8,174 shares — an estimated $229K sold.

Zacks Investment Management first reported a position in BRLI in Q3 2014 and held it in 1 quarter. The position peaked at $229K in Q3 2014. 182 funds tracked by Wall St. Rank hold BRLI as of Q4 2014.

  • Zacks Investment Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q4 2014 after selling out during the quarter.
  • Zacks Investment Management sold 8,174 BIO-REFERENCE LABS INC-NEW- shares in Q4 2014, an estimated $229K.
  • Zacks Investment Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2014 and held it in 1 quarter.
  • Zacks Investment Management's BIO-REFERENCE LABS INC-NEW- position peaked at $229K in Q3 2014.
  • 182 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2014.

Based on Zacks Investment Management's 13F filing for Q4 2014, filed 13 Feb 2015.